z-logo
open-access-imgOpen Access
Endovascular or open surgical treatment of high-risk patients with infrainguinal peripheral arterial disease and critical limb ischemia
Author(s) -
Dragan Totić,
Vesna Sarajlic,
Haris Vranić,
Amel Hadžimehmedagić,
Nedžad Rustempašić,
Muhamed Djedović,
Haris Vukas,
Alen Ahmetašević
Publication year - 2020
Publication title -
medicinski glasnik
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.191
H-Index - 13
eISSN - 1840-2445
pISSN - 1840-0132
DOI - 10.17392/1143-20
Subject(s) - critical limb ischemia , arterial disease , medicine , peripheral , limb ischemia , endovascular treatment , ischemia , disease , vascular disease , surgery , cardiology , aneurysm
Aim To determine preferable type of treatment in our clinical circumstances by following two groups of patients with critical limb ischemia (CLI), who were treated endovascularly and surgically. Methods Research was carried out in the form of a prospective study of 80 patients with CLI and Trans-Atlantic Inter-Society Consensus (TASC) C or D type of arterial disease, with American Society of Anesthesiology (ASA) class III risk, who were randomly divided in two groups as per the treatment they received, surgical and endovascular. Patients were followed during 28 months using clinical examination and Duplex Ultrasound (DUS) in accordance with prescheduled control visits. Results There was a statistical difference between surgical and endovascular group in two years patency (82.5% vs. 55%; p=0.022) but it did not result in the difference in amputation free survival (AFS) (95% vs. 85%; p=0.171) or two-year freedom from major adverse limb events (MALE) (87.5 vs. 77.5; p=0.254). Also, there was no difference in the overall survival of patients (100% vs. 97.5%; p=0.317). Conclusion Initial endovascular treatment is a preferred form of the treatment for selected patient population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom